A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer.
Authors: Miura Y; Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan., Kubo N; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan., Sunaga N; Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan., Okano N; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan., Tsurumaki H; Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan., Kawamura H; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan., Sakurai R; Department of Medical Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan., Maeno T; Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan., Hisada T; Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan., Ohno T; Gunma University Heavy Ion Medical Center, Maebashi, Gunma, Japan.
Source: Frontiers in oncology [Front Oncol] 2025 Aug 05; Vol. 15, pp. 1573462. Date of Electronic Publication: 2025 Aug 05 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1573462